Esperion directors Justin Bateman and Ankit Pareek elected as six incumbent directors depart
I'm LongbridgeAI, I can summarize articles.Esperion Therapeutics has elected Justin Bateman and Ankit Pareek to its board of directors following the consummation of a merger. Consequently, six incumbent directors—J. Martin Carroll, Sheldon L. Koenig, Robert E. Hoffman, Craig Thompson, Jay P. Shepard, and Seth H.Z. Fischer—ceased their roles in accordance with the Merger Agreement.
Esperion elected Justin Bateman and Ankit Pareek to its board upon consummation of the Merger, with six incumbent directors ceasing to serve.
| Individual | J. Martin Carroll | Sheldon L. Koenig | Robert E. Hoffman | Craig Thompson | Jay P. Shepard | Seth H.Z. Fischer | Justin Bateman | Ankit Pareek |
| Role | Director | Director | Director | Director | Director | Director | Director | Director |
| Type of Change | Ceased to be director | Ceased to be director | Ceased to be director | Ceased to be director | Ceased to be director | Ceased to be director | Elected | Elected |
| Effective Date | Upon consummation of the Merger | Upon consummation of the Merger | Upon consummation of the Merger | Upon consummation of the Merger | Upon consummation of the Merger | Upon consummation of the Merger | Upon consummation of the Merger | Upon consummation of the Merger |
| Reason | Merger; in accordance with Merger Agreement | Merger; in accordance with Merger Agreement | Merger; in accordance with Merger Agreement | Merger; in accordance with Merger Agreement | Merger; in accordance with Merger Agreement | Merger; in accordance with Merger Agreement | Merger; in accordance with Merger Agreement | Merger; in accordance with Merger Agreement |
| Replacement Info | Justin Bateman and Ankit Pareek elected to the board | Justin Bateman and Ankit Pareek elected to the board | Justin Bateman and Ankit Pareek elected to the board | Justin Bateman and Ankit Pareek elected to the board | Justin Bateman and Ankit Pareek elected to the board | Justin Bateman and Ankit Pareek elected to the board | N/A | N/A |
| Background Details | Not disclosed | Not disclosed | Not disclosed | Not disclosed | Not disclosed | Not disclosed | Director of MergerCo prior to Effective Time | Director of MergerCo prior to Effective Time |
| Board/Committee Role Changes | Not disclosed | Not disclosed | Not disclosed | Not disclosed | Not disclosed | Not disclosed | Not disclosed | Not disclosed |
Original SEC Filing: Esperion Therapeutics, Inc. [ ESPR ] - 8-K - Jul. 13, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.